Literature DB >> 23175663

Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation.

Patrizia Chiusolo, Elisabetta Metafuni, Sabrina Giammarco, Silvia Bellesi, Nicola Piccirillo, Chiara Fanali, Massimo Castagnola, Cecilia Zuppi, Teresa De Michele, Giuseppe Leone, Simona Sica.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23175663     DOI： 10.1182/blood-2012-08-447326

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

Review 1.  Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review.

Authors:  Bashaar Alibrahim; Mohammed I Aljasser; Baljinder Salh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04

Review 2.  The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review.

Authors:  Alaa M Ali; John F DiPersio; Mark A Schroeder
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-05       Impact factor: 5.742

Review 3.  Graft-versus-host disease biomarkers: omics and personalized medicine.

Authors:  Sophie Paczesny; Nisha Raiker; Sam Brooks; Christy Mumaw
Journal:  Int J Hematol       Date:  2013-09       Impact factor: 2.490

Review 4.  Usefulness of Testing for Fecal Calprotectin in Pediatric Gastroenterology Clinical Practice.

Authors:  Eliza Lężyk-Ciemniak; Magdalena Tworkiewicz; Dominika Wilczyńska; Anna Szaflarska-Popławska; Aneta Krogulska
Journal:  Med Princ Pract       Date:  2020-10-29       Impact factor: 1.927

5.  Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.

Authors:  Birgit Adam; Michael Koldehoff; Markus Ditschkowski; Tanja Gromke; Michal Hlinka; Rudolf Trenschel; Lambros Kordeals; Nina K Steckel; Dietrich W Beelen; Tobias Liebregts
Journal:  Dig Dis Sci       Date:  2016-03-19       Impact factor: 3.199

Review 6.  Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.

Authors:  Sophie Paczesny; Christine Duncan; David Jacobsohn; Robert Krance; Kathryn Leung; Paul Carpenter; Catherine Bollard; Jamie Renbarger; Kenneth Cooke
Journal:  Proteomics Clin Appl       Date:  2014-10-30       Impact factor: 3.494

7.  Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Fryderyk Lorenz; Stefan Marklund; Mårten Werner; Richard Palmqvist; Björn Engelbrekt Wahlin; Anders Wahlin
Journal:  Sci Rep       Date:  2015-01-21       Impact factor: 4.379

Review 8.  Fecal Calprotectin as a Diagnostic and Prognostic Biomarker for Gastrointestinal Graft Versus Host Disease: A Systematic Review of Literature.

Authors:  Mustafa N Malik; Abdul Rafae; Ceren Durer; Seren Durer; Faiz Anwer
Journal:  Cureus       Date:  2019-02-27

Review 9.  Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sophia Chen; Robert Zeiser
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.